Get started
MMM

MEDLAB CLINICAL LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

MDC chart


Full chart

MDC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.07 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.93 AUD
Net income (FY)
‪−2.13 M‬ AUD
Revenue (FY)
‪11.89 K‬ AUD
Shares float
‪1.68 M‬
Beta (1Y)
−11.40

About MEDLAB CLINICAL LIMITED


Sector
Health Technology
Headquarters
Perth
Founded
2014
Website
medlab.co
ISIN
AU000000MDC8
FIGI
BBG008KR9GT4
Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. It operates through the Nutraceutical and Pharmaceutical Research segments. The Pharmaceutical Research segment focuses on depression and oncology, and the supply of cannabis-based medicines. The company was founded by Sean Hall on June, 2012 and is headquartered in Perth, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MDC news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MDC is 6.60 AUD — it has decreased by −4.21% in the past 24 hours. Watch MEDLAB CLINICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange MEDLAB CLINICAL LIMITED stocks are traded under the ticker MDC.
MDC reached its all-time high on Jan 25, 2018 with the price of 180.00 AUD, and its all-time low was 6.45 AUD and was reached on Jun 27, 2022. View more price dynamics on MDC chart.
See other stocks reaching their highest and lowest prices.
MDC stock is 4.39% volatile and has beta coefficient of −11.40. Track MEDLAB CLINICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is MEDLAB CLINICAL LIMITED there?
Today MEDLAB CLINICAL LIMITED has the market capitalization of ‪15.07 M‬, it has decreased by −0.86% over the last week.
Yes, you can track MEDLAB CLINICAL LIMITED financials in yearly and quarterly reports right on TradingView.
MEDLAB CLINICAL LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MDC net income for the last half-year is ‪−150.37 K‬ AUD, while the previous report showed ‪−1.98 M‬ AUD of net income which accounts for 92.41% change. Track more MEDLAB CLINICAL LIMITED financial stats to get the full picture.
No, MDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDLAB CLINICAL LIMITED EBITDA is ‪−2.26 M‬ AUD, and current EBITDA margin is ‪−18.99 K‬%. See more stats in MEDLAB CLINICAL LIMITED financial statements.
Like other stocks, MDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDLAB CLINICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDLAB CLINICAL LIMITED technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDLAB CLINICAL LIMITED stock shows the sell signal. See more of MEDLAB CLINICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.